A Multicentre Randomized Clinical Trial on Efficacy and Safety of Huxin Formula in Patients Undergoing Percutaneous Coronary Intervention

Table 4

Score of the quality of life scale for patients with EF > 50% (𝑥±𝑠).

Time	Group	𝑛	𝑥±𝑠	𝑍	𝑃
0 day	Control group	244	71.80±12.62	−0.24	0.81
	Treatment group	251	72.03±12.18
90 days	Control group	244	81.32±9.592	−0.42	0.68
	Treatment group	251	81.79±9.220
180 days	Control group	244	82.84±9.24	−0.67	0.51
	Treatment group	251	83.39±8.58
270 days	Control group	244	84.72±8.77	−0.66	0.51
	Treatment group	251	85.26±8.431
360 days	Control group	244	86.29±8.55	−1.04	0.30
	Treatment group	251	87.11±7.70